sugammadex

• “The latest setback came for the drug sugammadex, which is designed to reverse the effects of muscle relaxants given under general anesthesia during surgery.”

  The Wall Street Journal: Schering-Plough Postsurgery Drug Rejected by FDA

• “But in early August, the FDA decided to reject Schering-Plough Corp. 's sugammadex, a drug that helps patients recover from anesthesia, even though the panel decided unanimously to approve it.”

  The Wall Street Journal: FDA Rejects Advisers,

• “Thomas Koestler, said in a statement that the company was "surprised and disappointed" by the FDA's "non-approvable letter," which forestalls approval of sugammadex.”

  The Wall Street Journal: Schering-Plough Postsurgery Drug Rejected by FDA

• “The European Union's drug regulator had approved sugammadex earlier in the week; it will be marketed under the brand Bridion.”

  The Wall Street Journal: Schering-Plough Postsurgery Drug Rejected by FDA

• “Schering said it plans to meet with the FDA to discuss its concerns, and "to find a path forward with sugammadex.”

  The Wall Street Journal: Schering-Plough Postsurgery Drug Rejected by FDA

• “The list includes the cholesterol drug Cordaptive from Merck, the heart medication Kynapid from Cardiome Pharma and the anesthesia-complication drug sugammadex from Schering-Plough.”

  The Wall Street Journal: Drugs With Market Potential

• “The treatment, sugammadex, had received unanimous support from an FDA advisory panel in March.”

  The Wall Street Journal: Hardly Working

• “Cervarix and Arcoxia are on the market in Europe, while sugammadex has been recommended for approval there.”

  The Wall Street Journal: Drug Makers Say FDA Safety Focus

• “The FDA has delayed approval of Glaxo's cancer vaccine, Cervarix, and Schering-Plough's sugammadex, a drug designed to be used after surgeries to quickly undo the effects of muscle relaxants, and rejected Merck's pain medicine Arcoxia.”

  The Wall Street Journal: Drug Makers Say FDA Safety Focus

• “The drug, sugammadex, would be used to reverse the effects of muscle-paralyzing drugs used in some surgeries.”

  The Wall Street Journal: Schering Postsurgery Drug

Show 10 more examples...